Medicine HSN Code: GST Rate, Classification & Invoicing Guide for Businesses

    Tallysolutions

    Tally Solutions

    Jul 13, 2026

    30 second summary | The HSN code for medicines is used to classify pharmaceutical products for GST compliance, invoicing and tax reporting. Most medicines fall under HSN Chapter 30. From 22 September 2025, most medicines attract 5% GST, while 37 specified life-saving medicines are exempt from GST.

    The HSN (Harmonised System of Nomenclature) code for medicines is used to classify pharmaceutical products under Goods and Services Tax (GST), determine the applicable tax rate and ensure accurate invoicing and tax compliance. Most medicines are classified under HSN Chapter 30, Pharmaceutical Products, with specific headings covering medicaments, vaccines, blood products, surgical materials and other pharmaceutical preparations.

    The applicable GST rate depends on the product's HSN classification and the relevant government notifications.

    What is the HSN code for medicines?

    Chapter 30 of the HSN/customs tariff is broken into headings based on the nature of the product. Here are the details:

    Description

    HSN code

    Glands and other organs, dried, whether or not powdered, for organo-therapeutic uses; extracts of glands, other organs or their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included

    3001

    Extracts of glands or other organs or their secretions

    3001 20

    Liquid liver extracts

    3001 20 10

    Dry liver extracts

    3001 20 20

    Snake venom

    3001 20 30

    Other

    3001 20 90

    Other

    3001 90

    Of human origin

    3001 90 10

    Heparin and its salts

    3001 90 91

    Other

    3001 90 99

    Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions; modified immunological products, whether or not obtained or modified through biotechnological processes; vaccines; toxins; cultures of micro-organisms (excluding yeasts) and similar products

    3002

    Antisera, other blood fractions and immunological products, whether or not modified or obtained through biotechnological processes

    3002 10

    Malaria diagnostic test kits

    3002 11 00

    Antisera and other blood fractions

    3002 12

    Antisera for diphtheria

    3002 12 10

    Antisera for tetanus

    3002 12 20

    Antisera for rabies

    3002 12 30

    Antisera for snake venom

    3002 12 40

    Other antisera and blood fractions

    3002 12 90

    Unmixed immunological products, not put up in measured doses or in forms or packings for retail sale

    3002 13

    Unmixed immunological products, not put up in measured doses or in forms or packings for retail sale

    3002 13 10

    Mixed immunological products, not put up in measured doses or in forms or packings for retail sale

    3002 14

    Mixed immunological products, not put up in measured doses or in forms or packings for retail sale

    3002 14 10

    Immunological products put up in measured doses or in forms or packings for retail sale

    3002 15 00

    Other

    3002 19 00

    Vaccines for human medicine

    3002 20

    Single vaccines

    3002 20

    Single vaccine for cholera and typhoid

    3002 20 11

    Single vaccine for hepatitis

    3002 20 12

    Single vaccine for tetanus

    3002 20 13

    Single vaccine for polio

    3002 20 14

    Single vaccine for tuberculosis

    3002 20 15

    Single vaccine for rabies

    3002 20 16

    Single vaccine for Japanese encephalitis

    3002 20 17

    Single vaccine for whooping cough (pertussis)

    3002 20 18

    Other single vaccines

    3002 20 19

    Mixed vaccines

    3002 20

    Mixed vaccine for diphtheria, pertussis and tetanus (DPT)

    3002 20 21

    Mixed vaccine for diphtheria and tetanus (DT)

    3002 20 22

    Mixed vaccine for measles, mumps and rubella (MMR)

    3002 20 23

    Mixed vaccine for typhoid-paratyphoid (TAB) or typhoid-paratyphoid-cholera (TABC)

    3002 20 24

    Other mixed vaccines

    3002 20 29

    Vaccines for veterinary medicine

    3002 30 00

    Other

    3002 90

    Human blood

    3002 90 10

    Animal blood prepared for therapeutic, prophylactic or diagnostic uses

    3002 90 20

    Cultures of micro-organisms (excluding yeast)

    3002 90 30

    Toxins

    3002 90 40

    Other

    3002 90 90

    Medicaments (excluding goods of headings 3002, 3005 or 3006) consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale

    3003

    Medicaments containing penicillins or their derivatives with a penicillanic acid structure, or streptomycins or their derivatives

    3003 10 00

    Other medicaments containing antibiotics

    3003 20 00

    Medicaments containing hormones or other products of heading 2937

    3003

    Medicaments containing insulin

    3003 31 00

    Other medicaments containing hormones or other products of heading 2937

    3003 39 00

    Medicaments containing alkaloids or their derivatives

    3003

    Medicaments containing ephedrine or its salts

    3003 41 00

    Medicaments containing pseudoephedrine (INN) or its salts

    3003 42 00

    Medicaments containing norephedrine or its salts

    3003 43 00

    Other medicaments containing alkaloids or their derivatives

    3003 49 00

    Medicaments containing active antimalarial principles described in Sub-heading Note 2 to this Chapter

    3003 60 00

    Other medicaments

    3003 90

    Medicaments of the Ayurvedic system

    3003 90 11

    Medicaments of the Unani system

    3003 90 12

    Medicaments of the Siddha system

    3003 90 13

    Medicaments of the Homoeopathic system

    3003 90 14

    Medicaments of the Bio-chemic system

    3003 90 15

    Menthol crystals

    3003 90 21

    Milk of magnesia

    3003 90 22

    Bovine albumin and drugs of animal origin

    3003 90 31

    Merbromine National Formulary XII (Mercurochrome)

    3003 90 32

    Calcium sennoside

    3003 90 33

    Anaesthetic agents used in human or veterinary medicine or surgery

    3003 90 34

    Aluminium hydroxide gel

    3003 90 35

    Ketamine

    3003 90 36

    Other medicaments

    3003 90 90

    What GST rate applies to medicines?

    From 22 September 2025, most medicines will attract 5% GST, following recommendations from the 56th GST Council Meeting. In addition, 37 specified life-saving medicines, including those used to treat cancer, rare diseases and certain chronic conditions, are exempt from GST (Nil rate).

    The government retained a 5% GST on most medicines rather than fully exempting them, so manufacturers can continue to claim input tax credit (ITC). This helps reduce production costs and limits the impact of tax costs on medicine prices.

    Note: While most medicines now fall under the 5% GST rate, a few pharmaceutical or pharma-adjacent products continue to attract the 18% GST rate. One commonly cited example is nicotine polacrilex gum, which falls outside the standard medicine category.

    What are the HSN code requirements on GST invoices?

    The HSN code required on a GST invoice depends on your Aggregate Annual Turnover (AATO) in the preceding financial year. Businesses must print the prescribed number of HSN digits on invoices and report them in GST returns in accordance with CBIC Notification No. 78/2020-Central Tax.

    Aggregate Annual Turnover (AATO) in the preceding FY

    HSN digits required on invoices

    Up to ₹5 crore

    4-digit HSN mandatory on B2B invoices; optional on B2C

    Above ₹5 crore

    6-digit HSN mandatory on all invoices, B2B and B2C

    Exports / imports

    Full 8-digit HSN required to align with customs classification

    A few compliance details that pharma businesses frequently get wrong:

    • Table 12 of GSTR-1 is mandatory for all taxpayers: Since 1 January 2024, all registered taxpayers must report HSN-wise details in Table 12 of GSTR-1, regardless of turnover.
    • HSN codes must be selected from the GST portal: Under the Phase 3 rollout, manual entry of HSN codes and descriptions is no longer permitted. Taxpayers must select a valid HSN code from the portal's dropdown list, after which the description is auto-populated.
    • B2B and B2C supplies are reported separately: Table 12 contains separate sections for B2B and B2C transactions, and the GST portal validates these values against other GSTR-1 tables before submission.
    • Composition taxpayers must also report HSN codes: Although composition dealers issue a Bill of Supply instead of a tax invoice, they must comply with the applicable HSN digit requirement based on their turnover.
    • HSN digit requirements are based on the previous financial year's AATO: The applicable 4-digit or 6-digit requirement remains unchanged throughout the year, even if turnover changes.
    • Table 13 document reporting is mandatory where applicable: Taxpayers reporting B2B or B2C supplies must also complete the required document details in Table 13.

    What should pharma businesses check before issuing a GST invoice?

    To prepare a GST-compliant invoice for medicines, verify the following before issuing the invoice:

    • Use the correct HSN code at the applicable digit level (4, 6 or 8 digits) based on your turnover and the nature of the transaction.
    • Verify the applicable GST rate against the specific HSN tariff item. Do not assume all products under the same 4-digit HSN heading attract the same GST rate, as nil-rated, 5% and 18% items may coexist.
    • Apply the correct GST type: Charge CGST and SGST for intra-state supplies, and IGST for inter-state supplies and exports.
    • Maintain accurate product classification: Record brand status and packaging, as these may affect the classification of Ayurvedic, Unani and Siddha medicines.
    • Follow the revised pricing guidance: Following the September 2025 GST rate change, medicines already released into the market before 22 September 2025 did not require MRP re-labelling, provided manufacturers and marketing companies ensured price compliance through approved measures such as supplementary price lists.
    • Claim ITC correctly: ITC is generally available on taxable supplies but not on nil-rated or exempt supplies. Businesses making exempt supplies may also need to reverse proportionate ITC on common inputs, where applicable.

    What is the penalty for incorrect invoicing

    Incorrect invoicing can attract a general penalty of up to ₹25,000 under Section 125 of the CGST Act, depending on the nature of the non-compliance. In addition, using an incorrect HSN code on a B2B invoice can delay or deny the buyer's ITC claim until the error is corrected, even though the mistake originated with the seller.

    Conclusion

    Using the correct HSN code for medicines is essential for accurate GST classification, invoicing and tax reporting. Regularly reviewing product classifications, applying the correct GST rates and following HSN reporting requirements can help businesses avoid compliance issues, minimise reconciliation errors and maintain accurate financial records.

    TallyPrime simplifies HSN-based invoicing, GST reporting and inventory management, enabling pharma businesses to manage compliance efficiently while supporting smoother day-to-day operations.

    Published on July 13, 2026

    left-icon
    1

    of

    4
    right-icon

    India’s choice for business brilliance

    Work faster, manage better, and stay on top of your business with TallyPrime, your complete business management solution.

    Get 7-days FREE Trial!

    I have read and accepted the T&C
    Submit